Vertex Pharmaceuticals (NASDAQ: VRTX) has stood out over the past several years as a top biotech player, thanks to its work ...

Sigma Planning Corp’s holdings in Vertex Pharmaceuticals were worth $1,277,000 at the end of the most recent reporting period. Other institutional investors also recently modified their holdings of ...

Monroe Sequestration Partners (“MSP”), which is developing a major carbon sequestration hub in northern Louisiana, has sold a ...

Return on Assets (ROA): Zeta Global Holdings's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -4.95%, the company may face hurdles in ...

Adjacent angles are one of the earliest and most important concepts to learn in basic geometry, as they have applications in ...

We expect investors to focus on the launch plans of Arcturus Therapeutics Holdings Inc.’s ARCT self-amplifying mRNA (sa-mRNA) ...

It will be a big week ahead with dozens of major earnings releases, a Federal Reserve meeting, and the U.S. election.

Palantir, Microchip Technology, and Arm Holdings are among the technology firms reporting this week, while pharmaceutical ...

Pinnacle Associates Ltd. reduced its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 44.4% in the ...

National GRIP will deepen partnerships with deep tech venture capitalists (VCs) and venture builders, such as current NUS Grip 2.0 strategic partners Legend Capital, SOSV Investments LLC and Vertex ...